Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Streptokinase vs Heparin Nebulization in Severe ARDS
NCT03465085Phase 3Completed
- Sponsor
- Beni Suef University
- Start
- Feb 2016
- Primary completion
- Jan 2018
- Modality
- Recombinant Proteins and Enzymes, Small Molecules
01
Overview
A Phase 3 trial of streptokinase, heparin in acute respiratory distress syndrome (ARDS), sponsored by Beni Suef University. Started Feb 2016; status: completed.
02
Drugs
streptokinaseheparin
03
Conditions
acute respiratory distress syndrome (ARDS)
Beyond the preview
Go deeper on NCT03465085.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03465085.